{
  "id": 3556,
  "url": "https://nnemf.org/research/3556-conductive-keratoplasty-a-radiofrequency-based-technique-for-the",
  "title": "Conductive keratoplasty: a radiofrequency-based technique for the correction of hyperopia.",
  "authors": [
    "Marguerite B McDonald"
  ],
  "journal": "Transactions of the American Ophthalmological Society",
  "year": "2005",
  "doi": null,
  "pmid": "17057816",
  "abstract": "PURPOSE: To evaluate the data on the safety, effectiveness, and stability of conductive keratoplasty (CK), a thermal, radiofrequency-based technique for treating 0.75 to 3.00 diopters (D) of spherical hyperopia. METHODS: A prospective, consecutive series, multicenter clinical trial involving 400 hyperopic eyes was conducted by 19 surgeons at 12 centers. The treatment goal was emmetropia. Cohort follow-up was up to 2 years. RESULTS: At 12 months postoperatively, data were available for 97.5% (354/363) of eyes for efficacy variables and 98% (391/400) of eyes for safety variables. A total of 54% of the CK eyes showed 20/20 or better uncorrected visual acuity, and 92% showed 20/40 or better at 12 months. The mean postoperative manifest refractive spherical equivalent was within 0.50 D in 61% and within 1.00 D in 88%. After CK, eyes were approximately 0.50 D myopic at month 1 and effectively emmetropic at 6 months. At 24 months, there was a 20% loss of initial effect. Safety results showed a 2-line loss of best-corrected visual acuity in 2% of the CK-treated eyes. The incidence of induced cylinder of 2.00 D or greater was below 1%. CONCLUSION: The CK technique corrects low to moderate hyperopia effectively and safely and with acceptable stability. It spares the visual axis, does not require the creation of a large flap, and is not associated with postoperative dry eye. CK has value as an alternative to hyperopic LASIK for patients with hyperopia.",
  "effect": "benefit",
  "evidence": "moderate",
  "extraction": {
    "studyType": "other",
    "studyTypeLabel": "Other",
    "effectDirection": "benefit",
    "evidenceLabel": "Moderate",
    "population": "Hyperopic eyes (0.75 to 3.00 diopters spherical hyperopia) undergoing conductive keratoplasty",
    "sampleSize": "400",
    "exposure": "RF",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "In a prospective multicenter clinical trial of 400 hyperopic eyes, 54% achieved 20/20 or better uncorrected visual acuity and 92% achieved 20/40 or better at 12 months. Refractive outcomes were within 0.50 D in 61% and within 1.00 D in 88%; at 24 months there was a reported 20% loss of initial effect. Safety outcomes included a 2-line loss of best-corrected visual acuity in 2% of treated eyes and induced cylinder ≥2.00 D in <1%.",
    "outcomes": [
      "Uncorrected visual acuity (20/20 or better",
      "20/40 or better)",
      "Manifest refractive spherical equivalent accuracy (within 0.50 D",
      "within 1.00 D)",
      "Stability/Regression of refractive effect at 24 months",
      "Safety: loss of best-corrected visual acuity (2-line loss)",
      "Safety: induced cylinder (≥2.00 D)"
    ],
    "limitations": [
      "Radiofrequency exposure parameters (e.g.",
      "frequency",
      "power",
      "SAR) not reported in abstract",
      "No comparator/control group described in abstract",
      "Follow-up reported up to 2 years",
      "longer-term stability beyond 24 months not available in abstract"
    ],
    "keywords": [
      "conductive keratoplasty",
      "radiofrequency",
      "thermal technique",
      "hyperopia",
      "clinical trial",
      "multicenter",
      "safety",
      "effectiveness",
      "stability"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"other\",\n  \"exposure\": {\n    \"band\": \"RF\",\n    \"source\": \"medical device (conductive keratoplasty)\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Hyperopic eyes (0.75 to 3.00 diopters spherical hyperopia) undergoing conductive keratoplasty\",\n  \"sample_size\": 400,\n  \"outcomes\": [\n    \"Uncorrected visual acuity (20/20 or better; 20/40 or better)\",\n    \"Manifest refractive spherical equivalent accuracy (within 0.50 D; within 1.00 D)\",\n    \"Stability/Regression of refractive effect at 24 months\",\n    \"Safety: loss of best-corrected visual acuity (2-line loss)\",\n    \"Safety: induced cylinder (≥2.00 D)\"\n  ],\n  \"main_findings\": \"In a prospective multicenter clinical trial of 400 hyperopic eyes, 54% achieved 20/20 or better uncorrected visual acuity and 92% achieved 20/40 or better at 12 months. Refractive outcomes were within 0.50 D in 61% and within 1.00 D in 88%; at 24 months there was a reported 20% loss of initial effect. Safety outcomes included a 2-line loss of best-corrected visual acuity in 2% of treated eyes and induced cylinder ≥2.00 D in <1%.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"Radiofrequency exposure parameters (e.g., frequency, power, SAR) not reported in abstract\",\n    \"No comparator/control group described in abstract\",\n    \"Follow-up reported up to 2 years; longer-term stability beyond 24 months not available in abstract\"\n  ],\n  \"evidence_strength\": \"moderate\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"conductive keratoplasty\",\n    \"radiofrequency\",\n    \"thermal technique\",\n    \"hyperopia\",\n    \"clinical trial\",\n    \"multicenter\",\n    \"safety\",\n    \"effectiveness\",\n    \"stability\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/17057816/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=3556",
  "updated": "2026-02-13 07:28:35"
}